JF
NPCE icon

Jump Financial’s Neuropace NPCE Stock Holding History

Jump Financial’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,887
Closed -$222K – 2327
2026
Q1 		$222K Sell
16,887
-8,813
-34% -$132K ﹤0.01% 1617
2025
Q4 		$397K Buy
+25,700
New +$344K ﹤0.01% 1418
2025
Q3 		– Sell
-40,474
Closed -$451K – 2075
2025
Q2 		$451K Buy
40,474
+27,965
+224% +$350K ﹤0.01% 1275
2025
Q1 		$154K Buy
+12,509
New +$157K ﹤0.01% 1471
2024
Q3 		– Sell
-11,431
Closed -$86.4K – 1969
2024
Q2 		$86.4K Sell
11,431
-14,107
-55% -$142K ﹤0.01% 1656
2024
Q1 		$337K Buy
+25,538
New +$364K 0.01% 1386

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Jump Financial's NPCE Position: Q2 2026 in Review

Jump Financial sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 16,887 shares — an estimated $222K sold.

Jump Financial first reported a position in NPCE in Q1 2024 and held it in 6 quarters. The position peaked at $451K in Q2 2025. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Jump Financial reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 16,887 Neuropace shares in Q2 2026, an estimated $222K.
  • Jump Financial first reported a position in Neuropace in Q1 2024 and held it in 6 quarters.
  • Jump Financial's Neuropace position peaked at $451K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.